Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples